231 related articles for article (PubMed ID: 23483294)
21. A Rare Case of Macrophage Activation Syndrome Presenting as the First Manifestation of Systemic Lupus Erythematosus.
Poudel P; Swe T; Rayancha S
J Investig Med High Impact Case Rep; 2018; 6():2324709618812196. PubMed ID: 30480003
[TBL] [Abstract][Full Text] [Related]
22. Macrophage activation syndrome in children with systemic lupus erythematosus and children with juvenile idiopathic arthritis.
Bennett TD; Fluchel M; Hersh AO; Hayward KN; Hersh AL; Brogan TV; Srivastava R; Stone BL; Korgenski EK; Mundorff MB; Casper TC; Bratton SL
Arthritis Rheum; 2012 Dec; 64(12):4135-42. PubMed ID: 22886474
[TBL] [Abstract][Full Text] [Related]
23. Macrophage activation syndrome in a newborn: report of a case associated with neonatal lupus erythematosus and a summary of the literature.
Heijstek V; Habib M; van der Palen R; van Doorn R; Muller PH
Pediatr Rheumatol Online J; 2021 Feb; 19(1):13. PubMed ID: 33568193
[TBL] [Abstract][Full Text] [Related]
24. Bidirectional association between systemic lupus erythematosus and macrophage activation syndrome: a nationwide population-based study.
Huang LW; Wei JC; Chen DY; Chen YJ; Tang KT; Ko TM; Chen HH
Rheumatology (Oxford); 2022 Mar; 61(3):1123-1132. PubMed ID: 34146089
[TBL] [Abstract][Full Text] [Related]
25. Macrophage activation syndrome triggered by systemic lupus erythematosus flare: successful treatment with a combination of dexamethasone sodium phosphate, intravenous immunoglobulin, and cyclosporine: a case report.
Gouda W; Alsaqabi F; Moshrif A; Abbas AS; Abdel-Aziz TM; Islam MA
J Med Case Rep; 2021 Oct; 15(1):497. PubMed ID: 34620236
[TBL] [Abstract][Full Text] [Related]
26. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: A study of 103 episodes in 89 adult patients.
Gavand PE; Serio I; Arnaud L; Costedoat-Chalumeau N; Carvelli J; Dossier A; Hinschberger O; Mouthon L; Le Guern V; Korganow AS; Poindron V; Gourguechon C; Lavigne C; Maurier F; Labro G; Heymonet M; Artifoni M; Viau AB; Deligny C; Sene T; Terriou L; Sibilia J; Mathian A; Bloch-Queyrat C; Larroche C; Amoura Z; Martin T
Autoimmun Rev; 2017 Jul; 16(7):743-749. PubMed ID: 28483541
[TBL] [Abstract][Full Text] [Related]
27. Macrophage activation syndrome complicating rheumatic diseases in adults: case-based review.
Gilboa M; Bornstein G; Ben-Zvi I; Grossman C
Rheumatol Int; 2020 Apr; 40(4):663-669. PubMed ID: 31367795
[TBL] [Abstract][Full Text] [Related]
28. Acute pancreatitis in juvenile systemic lupus erythematosus: a manifestation of macrophage activation syndrome?
Campos LM; Omori CH; Lotito AP; Jesus AA; Porta G; Silva CA
Lupus; 2010 Dec; 19(14):1654-8. PubMed ID: 20837568
[TBL] [Abstract][Full Text] [Related]
29. Acute pancreatitis and macrophage activation syndrome in pediatric systemic lupus erythematosus: case-based review.
Lin Q; Zhang M; Tang H; Shen Y; Zhu Y; Xu Q; Li X
Rheumatol Int; 2020 May; 40(5):811-819. PubMed ID: 31377830
[TBL] [Abstract][Full Text] [Related]
30. Successful therapy of macrophage activation syndrome with dexamethasone palmitate.
Nakagishi Y; Shimizu M; Kasai K; Miyoshi M; Yachie A
Mod Rheumatol; 2016 Jul; 26(4):617-20. PubMed ID: 24754272
[TBL] [Abstract][Full Text] [Related]
31. Sustained hyperferritinemia in a child with macrophage activation syndrome secondary to systemic juvenile idiopathic arthritis - perforinopathy: case based review.
Çakan M; Aktay-Ayaz N; Gemici H; Annayev A; Çıtak A; Akçay A; Öztürk G
Turk J Pediatr; 2018; 60(5):598-603. PubMed ID: 30968645
[TBL] [Abstract][Full Text] [Related]
32. [Macrophage activation syndrome in children with rheumatic disorders: a retrospective study on 6 patients].
Hu J; Li CW; Ma JJ; Yin J; Wang XM; Huang WY; Zhang YM
Zhonghua Er Ke Za Zhi; 2006 Nov; 44(11):818-23. PubMed ID: 17274867
[TBL] [Abstract][Full Text] [Related]
33. Systemic lupus erythematosus associated with development of macrophage activation syndrome and disseminated aspergillosis.
Phoophiboon V; Brown P; Burns KEA
Can J Anaesth; 2023 Jul; 70(7):1255-1260. PubMed ID: 37349668
[TBL] [Abstract][Full Text] [Related]
34. Clinical features of macrophage activation syndrome in the adult northern Chinese population.
Li X; Qu B; Nie Y; Zhu G; Li W; Mu F
Lupus; 2014 Jul; 23(8):785-92. PubMed ID: 24682586
[TBL] [Abstract][Full Text] [Related]
35. Systemic lupus erythematosus complicated with macrophage activation syndrome mimicking COVID-19 multisystemic inflammatory syndrome in children.
Domínguez-Rojas J; Atamari-Anahui N; Chonlon-Murillo K; Tello M; Coronado-Muñoz Á
Bol Med Hosp Infant Mex; 2021; 78(6):642-646. PubMed ID: 34934208
[TBL] [Abstract][Full Text] [Related]
36. Macrophage activation syndrome in juvenile dermatomyositis: a systematic review.
Poddighe D; Dauyey K
Rheumatol Int; 2020 May; 40(5):695-702. PubMed ID: 31529231
[TBL] [Abstract][Full Text] [Related]
37. Macrophage Activation Syndrome in Paediatric Rheumatic Diseases.
Islam MI; Talukder MK; Islam MM; Laila K; Rahman SA
Mymensingh Med J; 2017 Apr; 26(2):356-363. PubMed ID: 28588173
[TBL] [Abstract][Full Text] [Related]
38. Clinical analysis of macrophage activation syndrome in adult rheumatic disease: A multicenter retrospective study.
Ke Y; Lv C; Xuan W; Wu J; Da Z; Wei H; Zhang M; Tan W
Int J Rheum Dis; 2020 Nov; 23(11):1488-1496. PubMed ID: 32885598
[TBL] [Abstract][Full Text] [Related]
39. [The clinical characteristics of macrophage activation syndrome secondary to systemic lupus erythematosus].
Jiang N; Li MT; Wu D; Zeng XF
Zhonghua Nei Ke Za Zhi; 2016 Nov; 55(11):840-844. PubMed ID: 27801337
[No Abstract] [Full Text] [Related]
40. Macrophage activation syndrome associated with griscelli syndrome type 2: case report and review of literature.
Sefsafi Z; Hasbaoui BE; Kili A; Agadr A; Khattab M
Pan Afr Med J; 2018; 29():75. PubMed ID: 29875956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
